Identification of antiparasitic drug targets using a multi-omics workflow in the acanthocephalan model

被引：0
|
作者：
Hanno Schmidt
Katharina Mauer
Manuel Glaser
Bahram Sayyaf Dezfuli
Sören Lukas Hellmann
Ana Lúcia Silva Gomes
Falk Butter
Rebecca C. Wade
Thomas Hankeln
Holger Herlyn
机构：
[1] Johannes Gutenberg University Mainz,Institute of Organismic and Molecular Evolution (iomE), Anthropology
[2] Present address: Institute for Virology,Molecular and Cellular Modeling
[3] University Medical Center of the Johannes Gutenberg University Mainz,Department of Biology and Evolution
[4] Heidelberg Institute for Theoretical Studies,Institute of Organismic and Molecular Evolution (iomE), Molecular Genetics and Genomic Analysis
[5] University of Ferrara,Present address: Nucleic Acids Core Facility
[6] Johannes Gutenberg University Mainz,Quantitative Proteomics
[7] Johannes Gutenberg University Mainz,Center for Molecular Biology (ZMBH) and Interdisciplinary Center for Scientific Computing (IWR)
[8] Federal University of Amazonas,undefined
[9] LAPAA,undefined
[10] Institute of Molecular Biology (IMB),undefined
[11] Heidelberg University,undefined
来源：
BMC Genomics | / 23卷
关键词：
Parasites; Anthelmintics; Target molecule; Virtual ligand screening; Active ingredients; Medical genomics;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] Multi-Omics Reveals IBS Therapeutic Targets
    不详
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2020, 108 (06) : 1121 - 1121
  • [22] Identification of Targets for Cholangiocarcinoma by Multi-omics and Regulatory Element Assessment of Gene Expression
    Mimori, Koshi
    CANCER SCIENCE, 2025, 116 : 21 - 21
  • [23] Identification of Druggable Targets through Functional Multi-Omics in Renal Medullary Carcinoma
    Hong, Andrew L.
    Tseng, Yuen-Yi
    Kynnap, Bryan D.
    Doshi, Mihir B.
    Sandoval, Gabriel
    Oh, Coyin
    Sayeed, Abeer
    Shubhroz, Gill
    Church, Alanna J.
    Keskula, Paula
    Peng, Anson
    Clemons, Paul A.
    Tsherniak, Aviad
    Vazquez, Francisca
    Rodriguez-Galindo, Carlos
    Janeway, Katherine A.
    Garraway, Levi A.
    Schreiber, Stuart L.
    Root, David E.
    Mullen, Elizabeth
    Stegmaier, Kimberly
    Kadoch, Cigall
    Roberts, Charles W. M.
    Boehm, Jesse S.
    Hahn, William C.
    MOLECULAR CANCER THERAPEUTICS, 2017, 16 (10)
  • [24] A supervised Bayesian factor model for the identification of multi-omics signatures
    Gygi, Jeremy P.
    Konstorum, Anna
    Pawar, Shrikant
    Aron, Edel
    Kleinstein, Steven H.
    Guan, Leying
    BIOINFORMATICS, 2024, 40 (05)
  • [25] Advances in Integrated Multi-omics Analysis for Drug-Target Identification
    Du, Peiling
    Fan, Rui
    Zhang, Nana
    Wu, Chenyuan
    Zhang, Yingqian
    BIOMOLECULES, 2024, 14 (06)
  • [26] Prioritization of therapeutic targets for cancers using integrative multi-omics analysis
    Jin, Xin
    Mei, Yunyun
    Yang, Puyu
    Huang, Runze
    Zhang, Haifeng
    Wu, Yibin
    Wang, Miao
    He, Xigan
    Jiang, Ziting
    Zhu, Weiping
    Wang, Lu
    HUMAN GENOMICS, 2024, 18 (01)
  • [27] DRN-CDR: A cancer drug response prediction model using multi-omics and drug features
    Saranya, K. R.
    Vimina, E. R.
    COMPUTATIONAL BIOLOGY AND CHEMISTRY, 2024, 112
  • [28] A multi-view multi-omics model for cancer drug response prediction
    Zhijin Wang
    Ziyang Wang
    Yaohui Huang
    Longquan Lu
    Yonggang Fu
    Applied Intelligence, 2022, 52 : 14639 - 14650
  • [29] A multi-view multi-omics model for cancer drug response prediction
    Wang, Zhijin
    Wang, Ziyang
    Huang, Yaohui
    Lu, Longquan
    Fu, Yonggang
    APPLIED INTELLIGENCE, 2022, 52 (13) : 14639 - 14650
  • [30] Multi-Omics Analysis Identified Drug Repurposing Targets for Chronic Obstructive Pulmonary Disease
    Wang, Fang
    Barrero, Carlos A.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (20)
12345